Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2026-02-23 @ 8:57 PM
Study NCT ID:
NCT04090034
Status:
UNKNOWN
Last Update Posted:
2024-03-27
First Post:
2019-09-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
Sponsor:
Methodist Health System
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
022.HPB.2019.D
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None